Mdxhealth to Present at Upcoming Investor Conferences

Rhea-AI Summary

Mdxhealth, a commercial-stage precision diagnostics company, announced that CEO Michael K. McGarrity will present at two upcoming investor conferences in June 2024. The conferences are the William Blair 44th Annual Growth Stock Conference on June 5th at 5:00pm ET and the Jefferies Global Healthcare Conference on June 6th at 1:30pm ET. Both presentations will be webcast live and accessible through Mdxhealth's Investor page, with replays available for up to 60 days.

Positive

• CEO Michael K. McGarrity will represent Mdxhealth, potentially boosting investor confidence.
• Participation in high-profile conferences may increase visibility and attract new investors.
• Live webcasts and replay availability offer accessibility and transparency to stakeholders.

Negative

• No new clinical or financial data announced ahead of the presentations.
• Potential high expectations from investors may create pressure on the stock.

       

Mdxhealth to Present at Upcoming Investor Conferences

IRVINE, CA, and HERSTAL, BELGIUM – May 15, 2024 (GlobeNewswire) – Mdxhealth SA (Nasdaq: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, Chief Executive Officer, will participate in the following investor conferences in June 2024.

William Blair 44^th Annual Growth Stock Conference
Presentation: Wednesday, June 5, at 5:00pm ET
Webcast: https://wsw.com/webcast/blair97/mdxh/1942906

Jefferies Global Healthcare Conference
Presentation: Thursday, June 6, at 1:30pm ET
Webcast: https://wsw.com/webcast/jeff302/mdxh/1846928

Live webcasts of the presentations will be accessible on the Investor page of mdxhealth’s website at https://mdxhealth.com/presentations-events/. Replays will be available for up to 60 days following each event.

About mdxhealth®

Mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.

For more information:

mdxhealth info@mdxhealth.com
LifeSci Advisors (IR & PR) US: +1 518-221-0106 ir@mdxhealth.com

NOTE: The mdxhealth logo, mdxhealth, Confirm mdx, Select mdx, Resolve mdx, Genomic Prostate Score, GPS and Monitor mdx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.

 

Attachment

• MDXH June Conferences

FAQ

What investor conferences will Mdxhealth participate in during June 2024?

Mdxhealth will participate in the William Blair 44th Annual Growth Stock Conference on June 5th and the Jefferies Global Healthcare Conference on June 6th.

When is the Mdxhealth presentation at the William Blair 44th Annual Growth Stock Conference?

The presentation will be on June 5, 2024, at 5:00pm ET.

When is the Mdxhealth presentation at the Jefferies Global Healthcare Conference?

The presentation will be on June 6, 2024, at 1:30pm ET.

Where can I access the live webcasts of Mdxhealth's investor conference presentations?

The live webcasts can be accessed on the Investor page of Mdxhealth's website.

How long will the replays of Mdxhealth's presentations be available?

Replays will be available for up to 60 days following each event.